Ellicott City, Md.-based RxTrials, an investigative site network and consulting firm, has appointed Adam Chasse president.

"Adam has served as chief operating officer of RxTrials, where he has consistently proven his ability to successfully drive innovation and lead large-scale initiatives," said Christine Pierre, founder of RxTrials. “Additionally he has repeatedly demonstrated his innate capacity to develop and execute on a strategic vision for the company, growing RxTrials' site network from seven to 14 sites and expanding beyond the U.S. into South America.”

"This is an exciting time to be leading RxTrials, as we have such a unique blend of healthcare, site management and CRO/pharma experience among our management and staff," said Chasse. "The industry is aligning more strategically with site networks, which has led to RxTrials being able to support their studies in innovative ways that take full advantage of our team's diverse professional background."

Chasse joined RxTrials in 2011 as the vice president of corporate development, and soon after become chief operating officer. He has 16 years of experience in the pharmaceutical development industry; previously he was global head of prime sites at Quintiles.

Chasse became RxTrials president in October and will remain based in Raleigh, N.C.